Skip to main content
. 2011 May-Jun;4(3):140–149.

Table 2.

Medicaid Annual Spending on SABAs, ICSs, LABAs, and ICS/LABA Combinations, 1991–2010

Year Utilization, millions of prescriptions Spending, $ million Spending/prescription, $
Total SABA ICS LABA ICS/LABA Total SABA ICS LABA ICS/LABA Total SABA ICS LABA ICS/LABA
1991 8.9 7.0 1.9     180.7 144.3 36.4     20.39 20.72 19.19    
1992 11.6 8.9 2.7     253.4 192.9 60.5     21.93 21.75 22.53    
1993 13.3 10.0 3.3     307.0 223.6 83.4     23.01 22.31 25.15    
1994 13.1 9.5 3.6 0.0   320.7 222.2 98.2 0.3   24.48 23.44 27.15 45.82  
1995 13.0 9.4 3.5 0.1   338.5 226.2 108.3 3.9   26.07 24.09 30.84 50.03  
1996 12.1 7.9 4.1 0.1   328.9 187.5 135.8 5.5   27.19 23.76 33.16 51.13  
1997 11.6 7.1 4.4 0.1   334.8 164.4 164.0 6.5   28.75 23.03 37.33 54.88  
1998 10.3 6.8 3.5 0.0   286.5 136.3 147.7 2.5   27.76 20.17 42.00 55.24  
1999 11.9 8.1 3.8 0.1   338.2 158.6 174.2 5.4   28.33 19.65 46.11 62.58  
2000 12.9 8.7 4.1 0.1   392.3 173.5 210.2 8.6   30.35 19.94 51.30 67.44  
2001 14.9 9.5 4.8 0.2 0.4 610.6 269.3 277.6 10.9 52.8 40.88 28.29 57.58 71.17 119.60
2002 16.1 10.0 4.6 0.1 1.4 783.3 285.3 304.8 10.5 182.7 48.52 28.55 66.60 71.69 127.97
2003 18.5 11.0 4.6 0.4 2.5 1003.5 298.0 332.7 31.4 341.5 54.38 27.16 71.83 80.87 138.71
2004 19.4 10.8 4.7 0.6 3.4 1189.6 289.1 354.9 49.8 495.8 61.46 26.85 76.25 89.69 146.65
2005 20.8 11.6 4.9 0.4 3.9 1307.2 271.0 389.6 39.7 606.8 62.79 23.37 79.27 96.52 155.87
2006 14.0 8.4 3.8 0.1 1.8 1051.6 335.6 370.1 10.2 335.7 75.24 40.16 98.61 118.02 188.39
2007 14.0 8.4 3.8 0.1 1.8 1054.2 335.6 370.1 10.2 338.3 75.34 40.16 98.61 118.02 188.18
2008 14.6 8.5 4.0 0.1 2.0 1176.7 375.1 401.0 9.1 391.4 80.53 43.92 99.04 137.53 200.13
2009 15.6 8.9 4.6 0.1 2.0 1256.5 403.4 433.4 8.0 411.7 80.63 45.25 93.34 150.92 208.77

ICSs indicates inhaled corticosteroids; LABAs, long-acting beta-agonists; SABAs, short-acting beta-agonists.